Greenleaf Trust’s Morningstar MORN Stock Holding History

Greenleaf Trust’s Portfolio MORN Stock Details MORN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,340	Closed	-$291K	–	840
2025 Q4	$291K	Buy	+1,340	New	+$290K	﹤0.01%	668

Other funds holding MORN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Los Angeles Capital Management Los Angeles, California $27.2B AUM 43.16% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Greenleaf Trust's MORN Position: Q1 2026 in Review

Greenleaf Trust sold out of Morningstar (MORN) in Q1 2026, closing a stake of 1,340 shares — an estimated $291K sold.

Greenleaf Trust first reported a position in MORN in Q4 2025 and held it in 1 quarter. The position peaked at $291K in Q4 2025. 447 funds tracked by Wall St. Rank hold MORN as of Q1 2026.

Greenleaf Trust reported no remaining Morningstar position as of Q1 2026 after selling out during the quarter.
Greenleaf Trust sold 1,340 Morningstar shares in Q1 2026, an estimated $291K.
Greenleaf Trust first reported a position in Morningstar in Q4 2025 and held it in 1 quarter.
Greenleaf Trust's Morningstar position peaked at $291K in Q4 2025.
447 funds tracked by Wall St. Rank held Morningstar as of Q1 2026.

Based on Greenleaf Trust's 13F filing for Q1 2026, filed 27 Apr 2026.